Amplitude Ventures

Amplitude Ventures is a Montreal-based venture capital firm, founded in 2018, that focuses on precision medicine, investing at the intersection of biology and AI. The firm aims to support and scale companies that drive significant advancements in healthcare, particularly within Canada's innovation-rich ecosystem. Notable investments include Zymeworks, a biopharmaceutical company specializing in protein therapeutics, which went public in 2017, and Milestone Pharmaceuticals, known for its treatment for cardiovascular conditions, which also went public in 2019. Other key investments are DrugBank, a comprehensive drug database, and Valence Labs, which was acquired by Recursion. Amplitude Ventures recently closed a $263 million fund, significantly enhancing their capacity to invest in and grow cutting-edge precision medicine companies. The firm operates with a hands-on approach, providing strategic guidance and leveraging a strong network of industry experts. The leadership team includes co-founders Dion Madsen, Jean-François Pariseau, and Bharat Srinivasa, who bring extensive experience in life sciences and venture capital, ensuring robust support for their portfolio companies.